Table 4.
Multivariate cox proportional hazard analysis for risk factors of patients’ prognosis (DFS).
| Characteristics | DFS | ||
|---|---|---|---|
| HR (95%CI) | P value | ||
| Gender | Male | 1.0 (ref) | P=0.001 |
| Female | 0.67 (0.53,0.84) | ||
| Tumor size | <5cm | 1.0 (ref) | P=0.020 |
| ≥5cm | 1.25 (1.04,1.51) | ||
| T stage | T1 | 1.0 (ref) | P=0.080 |
| T2 | 1.63 (0.80,3.31) | ||
| T3 | 1.13 (0.54,1.95) | ||
| T4 | 1.11 (0.53,1.93) | ||
| N stage | N0 | 1.0 (ref) | P<0.001 |
| N1 | 1.43 (1.16,1.75) | ||
| N2 | 1.64 (1.31,2.06) | ||
| Metastasis | M0 | 1.0 (ref) | P<0.001 |
| M1 | 4.04 (3.19,5.12) | ||
| Adjuvant therapy | No | 1.0 (ref) | P=0.033 |
| Yes | 0.80 (0.65,0.98) | ||
| MA (Muscle attenuation) | 0.97 (0.97,0.98) | P<0.001 | |
| TAMA | 1.00 (0.99,1.01) | P=0.828 | |
| VFA | 1.01 (1.00,1.01) | P<0.001 | |
| PFA | 1.00 (0.99,1.01) | P=0.902 | |
| PMI | 1.00 (0.96,1.03) | P=0.801 | |
| LSMI (linear skeletal muscle index) | 0.93 (0.91,0.95) | P<0.001 | |
| SMI | 0.93 (0.90,0.96) | P<0.001 | |